Voxel S.A. (WSE:VOX)

Poland · Delayed Price · Currency is PLN

119.80

+1.20 (1.01%)

Jul 24, 2026, 5:00 PM CET

-31.31% (1Y)

Market Cap	1.26B -31.3%
Revenue (ttm)	583.14M +4.7%
Net Income	106.17M +4.6%
EPS	10.11 +4.7%
Shares Out	10.50M
PE Ratio	11.85
Forward PE	12.93
Dividend	4.78 (3.99%)
Ex-Dividend Date	Sep 29, 2026

Volume	7,322
Open	121.20
Previous Close	118.60
Day's Range	118.40 - 122.00
52-Week Range	93.80 - 180.00
Beta	0.57
Analysts	Buy
Price Target	144.40 (+20.53%)
Earnings Date	Aug 27, 2026

About Voxel

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2005

Employees 356

Stock Exchange Warsaw Stock Exchange

Ticker Symbol VOX

Full Company Profile

Financial Performance

In 2025, Voxel's revenue was 583.79 million, an increase of 14.97% compared to the previous year's 507.77 million. Earnings were 98.53 million, an increase of 2.16%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for VOX stock is "Buy." The 12-month stock price target is zł 144.40, which is an increase of 20.53% from the latest price.

Price Target

zł 144.40

(20.53% upside)

Analyst Consensus: Buy

Stock Forecasts